Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMYMP) Debt to Equity (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Debt to Equity for 17 consecutive years, with $2.44 as the latest value for Q4 2025.

  • Quarterly Debt to Equity fell 19.54% to $2.44 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.44 through Dec 2025, down 19.54% year-over-year, with the annual reading at $2.44 for FY2025, 19.54% down from the prior year.
  • Debt to Equity for Q4 2025 was $2.44 at Bristol Myers Squibb, down from $2.63 in the prior quarter.
  • The five-year high for Debt to Equity was $689.82 in Q4 2022, with the low at -$46.49 in Q3 2022.
  • Average Debt to Equity over 5 years is $54.49, with a median of $0.85 recorded in 2023.
  • The sharpest move saw Debt to Equity crashed 3307.47% in 2021, then soared 36781.07% in 2022.
  • Over 5 years, Debt to Equity stood at $1.87 in 2021, then skyrocketed by 36781.07% to $689.82 in 2022, then plummeted by 99.87% to $0.87 in 2023, then skyrocketed by 247.99% to $3.03 in 2024, then fell by 19.54% to $2.44 in 2025.
  • According to Business Quant data, Debt to Equity over the past three periods came in at $2.44, $2.63, and -$31.65 for Q4 2025, Q3 2025, and Q2 2025 respectively.